GSK 'Avandia' which disappeared from the market with the reason of cardiovascular safety controversy in 2011, will soon be re-released

Medical community is expecting that GSK 'Avandia' which disappeared from the market with the reason of cardiovascular safety controversy in 2011, will soon be re-released. Because last November which is 2 year after the safety controversy, the U.S. FDA gave indulgence to 'Avandia' that it does not increase the risk of heart-related diseases.

Medical community is accepting the re-release of Ava...